In China, over 250,000 cancer patients have participated in clinical trials in Chinese Medicine, while across China, Chinese Medicine is widely used to complement medical intervention (Xun el al., 2013).
In the systematic review of 2,385 randomised clinical trials and 579 non-randomised trials, most of the studies assessed the benefit of treatment in the reduction of the side effects of chemotherapy and radiation therapy: cancer pain; post-surgery recovery; and the prevention of relapse and metastasis. (Xun el al., 2013). However, across the board, the research models were often poor and more well designed clinical trials need to be conducted on this subject to be able to give good evidence of efficacy..
1. Boon et al., (2007) Trends in Complementary/Alternative medicine use by breast cancer survivors: comparing survey data from 1990 and 2005. BMC Women’s Health 30: 4.
2. Gou et al., (2012) Herbal medicines for advanced colorectal cancer. Cochrane database of systematic reviews.
3. Jia L. (2012) Cancer complementary and alternative medicine research at the US National Cancer Institute. Chin J Interg Med 18: 325-332.
4. Li PW (2003) Management of cancer with Chinese Medicine. Dominica Publishing.
5. Ni et al (2012) Chinese herbal medicine for advanced pancreatic cancer (Protocol). Cochrane database of systematic reviews.
6. Xun et al., (2013) Traditional Chinese Medicine in Cancer Care: A review of controlled clinical studies published in Chinese. PLoS ONE 8(4): e60338. do: 10.1371/journal.pone.0060338.